The findings of this meta-analysis suggest that GLP-1 receptor agonists are not associated with an increased risk of gastrointestinal cancers and were not associated with increased gastrointestinal cancer risk and demonstrated pooled estimates below unity for colorectal and liver cancers, findings that should be interpreted as hypothesis-generating rather than confirmatory of cancer prevention (Lingvay et al., 2018
Is it safe to take semaglutide the morning of surgery
Using it alongside excess calorie surplus can mask its fat-burning effects and hinder visible progress
Once reconstituted (mixed with bacteriostatic water), the peptides should be stored in the refrigerator to maintain stability
Phase I II study of idarubicin and cytarabine (ARA C) in acute leukemia
Mega-dose sodium ascorbate: a pilot, single-dose, physiological effect, double-blind, randomized, controlled trial